Sitafloxacin

From Self-sufficiency
Jump to: navigation, search
Sitafloxacin
File:Sitafloxacin.png
Systematic (IUPAC) name
7- [(4S)- 4-amino- 6-azaspiro [2.4] heptan- 6-yl]- 8-chloro- 6-fluoro- 1- [(2S)- 2-fluorocyclopropyl]- 4-oxoquinoline- 3-carboxylic acid
Clinical data
Routes of
administration		 Oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 127254-12-0
ATC code none
PubChem CID 73011
Chemical data
Formula C19H18ClF2N3O3
Molar mass 409.81[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis)
Other/ungrouped
Combinations
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication)
Related agents (DG)
Anaerobic DNA
inhibitors
Nitro- imidazole derivatives
Nitrofuran derivatives
RNA synthesis

M: BAC

drug(J1p, w, n, m, vacc)

50px This systemic antibacterial-related article is a stub. You can help ssf by expanding it.
it:Sitafloxacina ja:シタフロキサシン
  1. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Sitafloxacin&oldid=22986"